1. 5 FDA approval decisions to watch for in Q4 — Can general practitioners survive COVID-19? — 7 former FDA commissioners write opinion column lamenting White House's treatment of agency — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

R$D confused inundate with innovation

Discussion in 'Amylin' started by Anonymous, Feb 11, 2012 at 2:28 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Somebody give em' the dictionary.
     

  2. Anonymous

    Anonymous Guest

    Specious argument. Sitting around the labs laughing at you and collecting our HUGE salaries and bonuses! LOL!
     
  3. Anonymous

    Anonymous Guest

    Brain in veggie state after 4 years of inactivity. Gym keeping my body in good shape. Body good, brain not good. Compensation good. Can't live without it. Can't do hard work ever.
     
  4. Anonymous

    Anonymous Guest

    Good self-insight. Now get back to selling and marketing!
     
  5. Anonymous

    Anonymous Guest

    R & D needs to be rejuvenated. It need fearless leaders with vision and passion for science, not crap and jokers from fourth floor of 4570 who are in amylin to collect fat check and warming chairs.
     
  6. Anonymous

    Anonymous Guest

    Looks like we will have clean sweep of 4 th floor
     
  7. Anonymous

    Anonymous Guest

    Don't need DR LP JK DP SG ... quite a savings to rid them or downgrade them; no more R&D work, no more Lilly work. Sr Dirs can do their job adequately for a lot less.
     
  8. Anonymous

    Anonymous Guest

    who?
     
  9. Anonymous

    Anonymous Guest

    Current R & D leadership contributed zero to build pipeline. Amylin's drugs were build by visionaries with excellent leadership skills with passion for science. Unfortunately, non of them work with Amylin now.

    1] Exenatide franchise - Credit goes to Andrew Young (now in GSk)

    2] Pramlintide franchise - Credit goes to Ted Green

    3] Leptin franchise - Credit goes to Alain Baron

    For R & D to excel, current leaders should be kicked out deep in pacific ocean (so that they should never return back to Amylin) and hire back all or some of leaders mentioned above.
     
  10. Anonymous

    Anonymous Guest

    We do no we need R&D we need to be lean and mean for the buyer of Amylin.
    Read the tea leaves
     
  11. Anonymous

    Anonymous Guest

  12. Anonymous

    Anonymous Guest

    PM has a joke for PD. Confusius says PD thinks RnD is abbreviation for round and BMS is giving em horses to do the merry go around.
     
  13. Anonymous

    Anonymous Guest

  14. Anonymous

    Anonymous Guest

    You are an AssH---.
    Power monger and dictators without power are like fish without water. They will drown
    (F---) you first to hold their job/titles.
    do the reality check for yourself.... collect the package and get lost...